Invention Grant
- Patent Title: Anaplastic lymphoma kinase (ALK) as oncoantigen for lymphoma vaccination
-
Application No.: US14658774Application Date: 2015-03-16
-
Publication No.: US09650614B2Publication Date: 2017-05-16
- Inventor: Roberto Chiarle , Giorgio Inghirami , Guido Forni
- Applicant: Roberto Chiarle , Giorgio Inghirami
- Applicant Address: IT Savigliano (Cuneo) IT Castelnuovo Don Bosco (Asti)
- Assignee: Roberto Chiarle,Giorgio Inghirami
- Current Assignee: Roberto Chiarle,Giorgio Inghirami
- Current Assignee Address: IT Savigliano (Cuneo) IT Castelnuovo Don Bosco (Asti)
- Agency: Nixon & Vanderhye P.C.
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A61P35/00 ; C12N9/12 ; A61K39/00 ; A61K45/06 ; A61K31/704
Abstract:
Use of intracytoplasmatic domain of Anaplastic Lymphoma Kinase (ALK) protein and/or a nucleic acid molecule encoding for the intracytoplasmatic domain of Anaplastic Lymphoma Kinase (ALK) protein, of any species, for the preparation of a medicament, preferably a vaccine, for the treatment and/or prevention of a tumor in a subject, preferably a lymphoma.
Public/Granted literature
- US20150232820A1 ANAPLASTIC LYMPHOMA KINASE (ALK) AS ONCOANTIGEN FOR LYMPHOMA VACCINATION Public/Granted day:2015-08-20
Information query
IPC分类:
